Whitehawk Therapeutics, Inc. — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aerpio Pharmaceuticals, Inc. (ARPO)
CIK: 0001422142
Period of Report: 2021-02-01

Reporting Person: Dugel Pravin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-01	Stock Option (Right to Buy)	$1.46	A	17857	Acquired	2031-02-01	Common Stock (17857)	Direct

Footnotes

F1: Options shall vest in four equal quarterly installments beginning on February 1, 2021.